Otonomy Announces Pricing of Initial Public Offering
August 13, 2014Otonomy, Inc. announced the pricing of its initial public offering of 6,250,000 shares of common stock at a price to the public of $16.00 per share. Shares began trading on the NASDAQ Global Select Market on August 13, 2014, under the symbol “OTIC”.
More »
NeuroPace RNS® System Receives Approval from CMS for New Technology Add-On Payments
August 6, 2014NeuroPace announced the Centers for Medicare & Medicaid Services (CMS) has approved New Technology Add-on Payments (NTAP) for the RNS System, the world’s only commercially available implantable closed-loop responsive neurostimulator system.
More »
Marinus Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering
July 31, 2014Marinus Pharmaceuticals announced the pricing of its IPO of 5,625,000 shares of its common stock at a public offering price of $8.00 per share, before underwriting discounts. Trading begins on July 31 on the NASDAQ Global Market under the ticker “MRNS”.
More »